Squarepoint’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2M | Sell |
472,145
-483,482
| -51% | -$40.1M | 0.04% | 239 |
|
|
2025
Q1 | $77.5M | Buy |
955,627
+363,277
| +61% | +$29.5M | 0.09% | 111 |
|
|
2024
Q4 | $53.3M | Buy |
+592,350
| New | +$53.3M | 0.05% | 154 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 3099 |
|
|
2024
Q2 | – | Sell |
-134,571
| Closed | -$12.8M | – | 3052 |
|
|
2024
Q1 | $12.8M | Sell |
134,571
-588,391
| -81% | -$55.8M | 0.02% | 410 |
|
|
2023
Q4 | $64.6M | Sell |
722,962
-117,101
| -14% | -$10.5M | 0.12% | 90 |
|
|
2023
Q3 | $61.3M | Buy |
+840,063
| New | +$61.3M | 0.15% | 67 |
|
|
2023
Q2 | – | Sell |
-454,879
| Closed | -$34.7M | – | 2893 |
|
|
2023
Q1 | $34.7M | Buy |
+454,879
| New | +$34.7M | 0.14% | 93 |
|
|
2022
Q4 | – | Sell |
-79,567
| Closed | -$6.31M | – | 2662 |
|
|
2022
Q3 | $6.31M | Buy |
+79,567
| New | +$6.31M | 0.03% | 387 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2702 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2898 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2859 |
|
|
2021
Q3 | – | Sell |
-61,665
| Closed | -$8.35M | – | 2800 |
|
|
2021
Q2 | $8.35M | Buy |
61,665
+22,295
| +57% | +$3.02M | 0.03% | 328 |
|
|
2021
Q1 | $5.34M | Sell |
39,370
-222,341
| -85% | -$30.2M | 0.03% | 404 |
|
|
2020
Q4 | $36.8M | Buy |
261,711
+8,246
| +3% | +$1.16M | 0.28% | 40 |
|
|
2020
Q3 | $28.2M | Buy |
+253,465
| New | +$28.2M | 0.38% | 38 |
|
|
2020
Q1 | – | Sell |
-170,618
| Closed | -$16.2M | – | 2525 |
|
|
2019
Q4 | $16.2M | Buy |
+170,618
| New | +$16.2M | 0.1% | 181 |
|